13.07.2015 Views

Richtlijn: Niet-kleincellig longcarcinoom (2.0) - Kwaliteitskoepel

Richtlijn: Niet-kleincellig longcarcinoom (2.0) - Kwaliteitskoepel

Richtlijn: Niet-kleincellig longcarcinoom (2.0) - Kwaliteitskoepel

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Richtlijn</strong>: <strong>Niet</strong>-<strong>kleincellig</strong> <strong>longcarcinoom</strong> (<strong>2.0</strong>)53 - Birdas TJBirdas TJ, Koehler RP, Colonias A, et al. Sublobar resection with brachytherapy versus lobectomy forstage Ib nonsmall cell lung cancer. Ann Thorac Surg 81:434–438, discussion 438-439, 2006.54 - Birkmeyer JDBirkmeyer JD, Siewers AE, Finlayson EVA, et al. Hospital volume and surgical mortality in the UnitedStates. New Engl J Med 346:1128-1137, 2002.55 - Blanke CBlanke C, Ansar R, Mantravadi R, Gonin R. Phase III trial of thoracic irradiation with or without cisplatin forlocally advanced unresectable non-small cell lung cancer: a Hoosier Oncology Group protocol. J Clin Oncol13:1425-1429, 1995.56 - Blasberg JBlasberg J, Pass HI, Donington JS. Sublobar resection, a movement from the Lung Cancer Sudy Group. JThor Oncol 5:10, 1583-1593, 2010.57 - Blauwdruk kanker en werkBlauwdruk kanker en werk. http://www.oncoline.nl/kanker-en-werk, 200958 - Boland GWBoland GW, Goldberg MA, Lee MJ, Mayo-Smith WW, Dixon J, McNicholas MM, et al. Indeterminateadrenal mass in patiënts with cancer: Evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology194:131-134, 1995.59 - Bollen ECMBollen ECM, Duin CJ van, Theunissen PHMH, Hof-Grootenboer BP van ‘t, Blijham GH. Mediastinal lymphnode dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg 55:961-966,1993.60 - Bolliger CTBolliger CT. Exercise capacity as a predictor of postoperative complications in lung resection candidates.Am J Respir Crit Care Med 151:1472-1480, 1995.61 - Bonner JABonner JA, McGinnis WL, Stella PJ, Marschke R-FJ, Sloan JA, Shaw EG, et al. The possible advantage ofhyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma:results of a North Central Cancer Treatment Group Phase III Study. Cancer 82:1037-1048, 1998.62 - Borne HW van denBorne HW van den, Pruyn JFA. Achtergronden en betekenis van lotgenotencontact bij kankerpatienten.Tilburg: IVA, 1983.63 - Borst GRBorst GR, Ishikawa M, Nijkamp J, Hauptmann M, Shirato H, Onimaru R, van den Heuvel MM, Belderbos J,Lebesque JV, Sonke JJ. Radiation pneumonitis in patiënts treated for malignant pulmonary lesions withhypofractionated radiation therapy. Radiother Oncol 91:307-313, 2009.64 - Boushy SFBoushy SF, Billig DM, North LB, Helgason AH. Clinical course related to preoperative and postoperativepulmonary function in patiënts with bronchogenic carcinoma. Chest 59:383-391, 1971.65 - Boyer MJBoyer MJ, Viney R, Fulham M, King M, McCaughan B, Kenny P, et al. A randomised trial of conventionalstaging (CS) with or without positron emission tomography (PET) in patiënts (Pts) with stage 1 or 2non-small cell lung cancer (NSCLC). ASCO , abstract 1233, 2001.66 - Bozcuk HBozcuk H, Martin C. Does treatment delay affect survival in non-small cell lung cancer? A retrospective06/09/2011 <strong>Niet</strong>-<strong>kleincellig</strong> <strong>longcarcinoom</strong> (<strong>2.0</strong>) 97

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!